Oct 1, 2026 | NEWS
An international genetic study led by scientists at Amgen deCODE genetics suggests that the hormone aldosterone is more important to the pathology of resistant hypertension than previously thought. One in six hypertensive Icelanders has a drug-resistant form of the...
Aug 19, 2026 | NEWS
Scientists at Amgen deCODE genetics have constructed the first Icelandic pangenome. A new method identifies 6% more genetic variants than previous methods and has already revealed a previously undetected variant associated with a substantially increased risk of...
Jul 30, 2026 | NEWS
In a landmark study published in Nature Medicine (https://www.nature.com/articles/s41591-026-04492-6), an international team of researchers have identified new genetic risk factors associated with fibromyalgia suggesting that the biological basis of the condition is...
May 15, 2026 | NEWS
deCODE genetics, a subsidiary of the global biotechnology company Amgen, today announced the appointment of Daníel F. Guðbjartsson, Ph.D. as Associate Vice President and Site Head. In this role, Dr. Guðbjartsson will lead site operations for deCODE genetics, further...
Mar 13, 2026 | NEWS
Bob Bradway with the leadership team of Amgen deCODE genetics. Bob Bradway, CEO of Amgen, visited the facilities of Amgen deCODE genetics (ADG) on Wednesday, March 11. During the visit he learned about the company’s operations, met with executives and...
Nov 20, 2025 | NEWS
In a paper published in Nature Genetics, researchers at Amgen deCODE genetics and collaborators report an important insight into the genetics of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) : a rare variant in the gene IKBKB (encoding the...
